The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma.

Jihyun An Hyo Jeong Kang Eunsil Yu Han Chu Lee Ju Hyun Shim

Published in: Journal of liver cancer (2022)

Immune checkpoint proteins upregulated in TIMCs in HCC tissues have individual and additive effects in prolonging the survival of patients, specifically in terms of survival not related to cancer recurrence.

Keyphrases

end stage renal disease
free survival
ejection fraction
newly diagnosed
chronic kidney disease
small molecule
gene expression
prognostic factors
papillary thyroid
patient reported outcomes
patient reported